These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36260325)

  • 1. Association of Serial High-Sensitivity Cardiac Troponin T With Subsequent Cardiovascular Events in Patients Stabilized After Acute Coronary Syndrome: A Secondary Analysis From IMPROVE-IT.
    Patel SM; Qamar A; Giugliano RP; Jarolim P; Marston NA; Park JG; Blazing MA; Cannon CP; Braunwald E; Morrow DA
    JAMA Cardiol; 2022 Dec; 7(12):1199-1206. PubMed ID: 36260325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial.
    Bach RG; Cannon CP; Giugliano RP; White JA; Lokhnygina Y; Bohula EA; Califf RM; Braunwald E; Blazing MA
    JAMA Cardiol; 2019 Sep; 4(9):846-854. PubMed ID: 31314050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial.
    Giugliano RP; Wiviott SD; Blazing MA; De Ferrari GM; Park JG; Murphy SA; White JA; Tershakovec AM; Cannon CP; Braunwald E
    JAMA Cardiol; 2017 May; 2(5):547-555. PubMed ID: 28291866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes: A Secondary Analysis of the DECLARE-TIMI 58 Trial.
    Zelniker TA; Wiviott SD; Mosenzon O; Goodrich EL; Jarolim P; Cahn A; Bhatt DL; Leiter LA; McGuire DK; Wilding J; Averkov O; Budaj A; Parkhomenko A; Ray KK; Gause-Nilsson I; Langkilde AM; Fredriksson M; Raz I; Sabatine MS; Morrow DA
    JAMA Cardiol; 2023 May; 8(5):503-509. PubMed ID: 36857035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
    Giugliano RP; Cannon CP; Blazing MA; Nicolau JC; Corbalán R; Špinar J; Park JG; White JA; Bohula EA; Braunwald E;
    Circulation; 2018 Apr; 137(15):1571-1582. PubMed ID: 29263150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
    Bohula EA; Wiviott SD; Giugliano RP; Blazing MA; Park JG; Murphy SA; White JA; Mach F; Van de Werf F; Dalby AJ; White HD; Tershakovec AM; Cannon CP; Braunwald E
    Circulation; 2017 Dec; 136(25):2440-2450. PubMed ID: 28972004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of High-Sensitivity Troponin T in Identifying Very-Low-Risk Patients With Possible Acute Coronary Syndrome.
    Peacock WF; Baumann BM; Bruton D; Davis TE; Handy B; Jones CW; Hollander JE; Limkakeng AT; Mehrotra A; Than M; Ziegler A; Dinkel C
    JAMA Cardiol; 2018 Feb; 3(2):104-111. PubMed ID: 29238804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial.
    Berg DD; Docherty KF; Sattar N; Jarolim P; Welsh P; Jhund PS; Anand IS; Chopra V; de Boer RA; Kosiborod MN; Nicolau JC; O'Meara E; Schou M; Hammarstedt A; Langkilde AM; Lindholm D; Sjöstrand M; McMurray JJV; Sabatine MS; Morrow DA
    Circulation; 2022 Jan; 145(3):158-169. PubMed ID: 34743554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention.
    Bohula EA; Morrow DA; Giugliano RP; Blazing MA; He P; Park JG; Murphy SA; White JA; Kesaniemi YA; Pedersen TR; Brady AJ; Mitchel Y; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2017 Feb; 69(8):911-921. PubMed ID: 28231942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
    Kato ET; Cannon CP; Blazing MA; Bohula E; Guneri S; White JA; Murphy SA; Park JG; Braunwald E; Giugliano RP
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT.
    Bohula EA; Giugliano RP; Cannon CP; Zhou J; Murphy SA; White JA; Tershakovec AM; Blazing MA; Braunwald E
    Circulation; 2015 Sep; 132(13):1224-33. PubMed ID: 26330412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.
    Murphy SA; Cannon CP; Blazing MA; Giugliano RP; White JA; Lokhnygina Y; Reist C; Im K; Bohula EA; Isaza D; Lopez-Sendon J; Dellborg M; Kher U; Tershakovec AM; Braunwald E
    J Am Coll Cardiol; 2016 Feb; 67(4):353-361. PubMed ID: 26821621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT).
    Sharma A; Sun JL; Lokhnygina Y; Roe MT; Ahmad T; Desai NR; Blazing MA
    Am J Cardiol; 2019 Apr; 123(8):1193-1201. PubMed ID: 30739657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Chest Pain Protocol-Discordant Discharge With Outcomes Among Emergency Department Patients With Modest Elevations of High-Sensitivity Troponin.
    Khan A; Saleem MS; Willner KD; Sullivan L; Yu E; Mahmoud O; Alsaid A; Matsumura ME
    JAMA Netw Open; 2022 Aug; 5(8):e2226809. PubMed ID: 35969395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery.
    ; Devereaux PJ; Biccard BM; Sigamani A; Xavier D; Chan MTV; Srinathan SK; Walsh M; Abraham V; Pearse R; Wang CY; Sessler DI; Kurz A; Szczeklik W; Berwanger O; Villar JC; Malaga G; Garg AX; Chow CK; Ackland G; Patel A; Borges FK; Belley-Cote EP; Duceppe E; Spence J; Tandon V; Williams C; Sapsford RJ; Polanczyk CA; Tiboni M; Alonso-Coello P; Faruqui A; Heels-Ansdell D; Lamy A; Whitlock R; LeManach Y; Roshanov PS; McGillion M; Kavsak P; McQueen MJ; Thabane L; Rodseth RN; Buse GAL; Bhandari M; Garutti I; Jacka MJ; Schünemann HJ; Cortes OL; Coriat P; Dvirnik N; Botto F; Pettit S; Jaffe AS; Guyatt GH
    JAMA; 2017 Apr; 317(16):1642-1651. PubMed ID: 28444280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT.
    Oyama K; Giugliano RP; Blazing MA; Park JG; Tershakovec AM; Sabatine MS; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2021 Oct; 78(15):1499-1507. PubMed ID: 34620406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy.
    Celik S; Giannitsis E; Wollert KC; Schwöbel K; Lossnitzer D; Hilbel T; Lehrke S; Zdunek D; Hess A; Januzzi JL; Katus HA
    Clin Res Cardiol; 2011 Dec; 100(12):1077-85. PubMed ID: 21792561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial.
    Qamar A; Giugliano RP; Bohula EA; Park JG; Jarolim P; Murphy SA; Blazing MA; Califf RM; Cannon CP; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2019 Aug; 74(8):1057-1068. PubMed ID: 31439215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive role of high sensitivity troponin T within four hours from presentation of acute coronary syndrome in elderly patients.
    Borna C; Frostred KL; Ekelund U
    BMC Emerg Med; 2016 Jan; 16():1. PubMed ID: 26728878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.